Cargando…

An Update on Novel Therapeutic Warfronts of Extracellular Vesicles (EVs) in Cancer Treatment: Where We Are Standing Right Now and Where to Go in the Future

Extracellular vesicles (EVs) are a heterogeneous group of membrane-bounded vesicles that are believed to be produced and secreted by presumably all cell types under physiological and pathological conditions, including tumors. EVs are very important vehicles in intercellular communications for both s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khawar, Muhammad Babar, Abbasi, Muddasir Hassan, Siddique, Zerwa, Arif, Amin, Sheikh, Nadeem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683766/ https://www.ncbi.nlm.nih.gov/pubmed/31428232 http://dx.doi.org/10.1155/2019/9702562

Ejemplares similares

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

Dichotomous role of autophagy in cancer
por: Arif, Amin, et al.
Publicado: (2022)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Yellow fever control in Cameroon: Where are we now and where are we going?
por: Wiysonge, Charles Shey, et al.
Publicado: (2008)

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

Structure functions and the EMC effect: where are we now and where are we going to?
por: Wimpenny, S J
Publicado: (1984)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
por: AHMED, MOHAMED H
Publicado: (2018)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Neutrino Masses and Mixing: Where We Stand and Where We are Going
por: Gonzalez-Garcia, M.C.
Publicado: (2002)

Alzheimer’s disease and infections, where we stand and where we go
por: Monastero, Roberto, et al.
Publicado: (2014)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Establishment of Fracture Liaison Service in Korea: Where Is It Stand and Where Is It Going?
por: Cha, Yong Han, et al.
Publicado: (2019)

A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation
por: Khawar, Babar, et al.
Publicado: (2015)

Biliary atresia: Where do we stand now?
por: Govindarajan, Krishna Kumar
Publicado: (2016)

Pembrolizumab in endometrial cancer: Where we stand now
por: Aravantinou-Fatorou, Aikaterini, et al.
Publicado: (2021)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Clinical chorioamnionitis: where do we stand now?
por: Lukanović, David, et al.
Publicado: (2023)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
por: Mader, Reuven, et al.
Publicado: (2022)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?
por: Gazerani, Parisa
Publicado: (2020)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

A Comprehensive Review on Bariatric Endoscopy: Where We Are Now and Where We Are Going
por: Mauro, Aurelio, et al.
Publicado: (2023)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Sympathetic Modulation in Cardiac Arrhythmias: Where We Stand and Where We Go
por: Chung, Wei-Hsin, et al.
Publicado: (2023)

IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis
por: Khawar, Muhammad Babar, et al.
Publicado: (2016)

Correction: Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
Publicado: (2017)

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020)

Breast Implant Surfaces and Their Impact on Current Practices: Where We Are Now and Where Are We Going?
por: Munhoz, Alexandre Mendonça, et al.
Publicado: (2019)

Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?
por: Giri, Paresh C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_48r45bdoqg34l7vfa7ncdulnu1